Celebrating 25 years Est 1999-2024
*Across 3 years $2276.64 only $1138.32
Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices NEW YORK, Dec. 10 /PRNewswire/...
RNS Number:6678U CeNeS Pharmaceuticals PLC 27 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The Company...
RNS Number:6672U CeNeS Pharmaceuticals PLC 27 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The Company...
RNS Number:4651U CeNeS Pharmaceuticals PLC 21 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The Company was...
RNS Number:4413U CeNeS Pharmaceuticals PLC 20 January 2004 CeNeS Pharmaceuticals plc Additional Listing Application has been made for...
RNS Number:3209U CeNeS Pharmaceuticals PLC 16 January 2004 CENES PHARMACEUTICALS PLC ("CeNeS" or "the Company") Notice of Extraordinary...
RNS Number:2346U CeNeS Pharmaceuticals PLC 14 January 2004 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The...
The Company received notification today that a client of ISIS Asset Management plc, Active Capital Trust, following the disposal of 4,500,000...
Cambridge, UK, 12 January 2004 - CeNeS Pharmaceuticals plc (LSE: CEN) ("CeNeS" or "the Company"), is pleased to announce the appointment of Piper...
RNS Number:9745T CeNeS Pharmaceuticals PLC 08 January 2004 CeNeS announces appointment of Alan Smith as non-executive director...
RNS Number:6054T CeNeS Pharmaceuticals PLC 23 December 2003 CeNeS Pharmaceuticals plc ("the Company") Directors' Shareholding The...
RNS Number:3911T CeNeS Pharmaceuticals PLC 17 December 2003 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The...
RNS Number:9628S CeNeS Pharmaceuticals PLC 08 December 2003 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY Following...
RNS Number:6497S CeNeS Pharmaceuticals PLC 28 November 2003 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The Company...
RNS Number:3923S CeNeS Pharmaceuticals PLC 24 November 2003 CeNeS Pharmaceuticals plc CeNeS strengthens its CNS pipeline by the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.